| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3901820 | Urology | 2012 | 9 Pages |
Abstract
The results of the present study have shown for the first time that a combination of DR4 and DR5 expression have significant value in predicting the prognosis of bladder cancer. In addition, patients with high expression of both DR4 and DR5 might benefit from epirubicin therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Yongnan Li, Xiudong Jin, Jinhua Li, Xinghua Jin, Jianbo Yu, Xiaodong Sun, Yanhui Chu, Chunyan Xu, Xiaoxia Li, Xijun Wang, Yoshiyuki kakehi, Xiuxian Wu,